Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - Pharmaceutical News - Ex-Rite Aid Stores chief executive to become CEO of GNC [Palestine News Network] - November 20, 2017

Pharmacy News Article

 9/7/17 - Ex-Rite Aid Stores chief executive to become CEO of GNC [Palestine News Network]

More than a year after GNC launched its search for a new CEO, the Pittsburgh-based vitamin and supplements retailer has found its new leader at long-time partner Rite Aid.

Ken Martindale takes the helm at GNC on Monday, becoming the fourth top executive since 2014 at the Downtown-based company. He has been CEO of Rite Aid stores and president of Rite Aid Corp the past two years, first joining the Camp Hill drug store chain in 2008.

Next year marks 20 years since GNC first partnered with the Rite Aid pharmacy chain to place more than 2,000 GNC stores-within-a-store at Rite Aid locations.

Mr. Martindale moves into the C-suite at GNC just nine months into its One New GNC rebranding strategy featuring simplified and reduced pricing and a new customer loyalty program. The moves are all part of the companys effort to return to earlier profitability in a vitamin and supplements sector buffeted by e-commerce competitors.

In a release Wednesday, Mr. Martindale expressed his deep admiration for GNC, the tremendous brand theyve built and, in particular, the successful work theyre doing to fundamentally transform the business model.

Since a highly successful initial public offering in 2011, GNC has seen its share price break $60 in November 2013, then steadily fall hitting a 12-month low of $6.51 earlier this year.

The decline has not been kind to GNC executives.

Shares were selling at $33.52 when long-time President and CEO Joe Fortunato left in August 2014 and $20.28 when Mr. Fortunatos replacement Mike Archbold was removed in July 2016. Mr. Archbolds interim replacement, Bob Moran, will now return to his earlier role as board chairman.

Rite Aid has had its own setbacks, most notably when Walgreens and Rite Aid abandoned efforts for Walgreens to buy its rival over concerns the deal would not receive regulatory approval. Instead, Walgreens officials said they would buy 2,186 Rite Aid stores in a $5.18 billion deal that would hand over nearly half of the smaller companys store locations.

Since January, Rite Aid shares have plummeted from $8.77 to less than $2.50.

GNC shares closed Wednesday at $8.24, up 2.36 percent from Tuesday`s $8.05 close.

GNC has about 600 employees at its headquarters Downtown.

(c) Palestine News Network, 2003 - 2017 Provided by SyndiGate Media Inc. (

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Nov 20: Obesity Management: Overview of Pharmacotherapy
Last Chance
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement